个性化文献订阅>期刊> Phytotherapy Research
 

Withanamides in Withania somnifera Fruit Protect PC-12 Cells from beta-Amyloid Responsible for Alzheimer's Disease

  作者 Jayaprakasam, B; Padmanabhan, K; Nair, MG  
  选自 期刊  Phytotherapy Research;  卷期  2010年24-6;  页码  859-863  
  关联知识点  
 

[摘要]Alzheimer's disease (AD) is an irreversible neurodegenerative disorder with symptoms of confusion, memory loss, and mood swings. The beta-amyloid peptide, with 39-42 amino acid residues (BAP), plays a significant role in the development of AD. Although there is no cure for AD, it can be managed with available drugs to some degree. Several studies have revealed that natural antioxidants, such as vitamin E, vitamin C and beta-carotene, may help in scavenging free radicals generated during the initiation and progression of this disease. Therefore, there has been considerable interest in plant phytochemicals with antioxidant property as potential agents to prevent the progression of AD. Our earlier investigations of the Withania somnifera fruit afforded lipid per. oxidation inhibitory withanamides that are more potent than the commercial antioxidants. In this study, we have tested two major withanamides A (WA) and C (WC) for their ability to protect the PC-12 cells, rat neuronal cells, from P-amyloid induced cell damage. The cell death caused by beta-amyloid was negated by withanamide treatment. Molecular modeling studies showed that withanamides A and C uniquely bind to the active motif of beta-amyloid (25-35) and suggest that withanamides have the ability to prevent the fibril formation. Further understanding of the mechanism of action and in vivo efficacy of these withanamides may facilitate its development as a prophylaxis. Copyright (C) 2009 John Wiley & Sons, Ltd.

 
      被申请数(0)  
 

[全文传递流程]

一般上传文献全文的时限在1个工作日内